MedPath

Electronic Proactive Outreach for Smokers With COPD

Not Applicable
Completed
Conditions
Smoking
Pulmonary Disease, Chronic Obstructive
Registration Number
NCT04462289
Lead Sponsor
VA Office of Research and Development
Brief Summary

Chronic obstructive pulmonary disease (COPD) is one of the most common respiratory diseases, with 90% of cases directly attributable to smoking. Unfortunately, many patients continue to smoke and have an urgent need to quit. Proactive tobacco treatment programs identify patients outside of a routine clinical appointment and engage them in making a supported quit attempt.

Most previous research of proactive tobacco treatment has used telephone outreach, which can be resource intensive. Electronic methods (texting, secure messaging) may be effective while requiring fewer resources.

In this study, the investigators will adapt a clinically available motivational texting program with content tailored to smokers with COPD. First, information will be gathered from smokers with COPD and the medical staff who care for them to adapt the program for electronic delivery. Then, the program will be pilot-tested. Smokers with COPD will be randomly assigned to either usual medical care or the outreach intervention, with goals to increase participation in smoking cessation programs, quit attempts, and successful cessation.

Detailed Description

Chronic obstructive pulmonary disease (COPD) is one of the most common respiratory conditions and the 4th leading cause of death in the US. 90% of cases are directly attributable to smoking. Quitting smoking is the most important intervention for these patients, who continue to smoke at rates double the national average. Smokers with COPD remain undertreated for tobacco use. Proactive tobacco treatment programs identify patients outside of a routine clinic visit, engage them in making a quit attempt and connect them with treatment. These programs may be particularly beneficial for smokers with COPD. Previous phone-based programs are resource intensive to deliver. Electronic methods for delivering proactive outreach for tobacco cessation may be effective and cost-effective, and can be tailored to the target population.

Hypothesis: A proactive tobacco treatment program delivered electronically and tailored to smokers with COPD will be effective and cost effective for increasing quit engagement among smokers with COPD.

Study design: Multi-aim implementation study with randomized pilot. Aim 1: Mixed methods (survey and interview) assessment of current use of health information technology among smokers with COPD with a focus on the impact of the chronic disease state on tobacco cessation.

Aim 2: Qualitative assessment of barriers and facilitators to implementation of proactive tobacco treatment programs for patients with COPD among staff and leadership.

Aim 3: Randomized pilot of a proactive tobacco treatment program for smokers with COPD delivered through text messaging.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
124
Inclusion Criteria
  • Veterans active in clinical care (at least one primary care or pulmonary visit within the past year)
  • Past-year smoking status in the electronic health record indicating current smoking, confirmed on enrollment call
  • Diagnosed with COPD (2 International Classification of Diseases (ICD)-10 diagnoses of COPD within the past 2 years)
  • Currently enrolled in MyHealtheVet secure messaging
Exclusion Criteria
  • Already enrolled in behavioral VA tobacco treatment
  • Enrolled in hospice
  • Undergoing active cancer treatment
  • Advanced dementia
  • Unable to communicate in English

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Participation in Tobacco Cessation Treatment6 months

Any participation in tobacco cessation treatment (medication use, counseling)

Secondary Outcome Measures
NameTimeMethod
Moved Upward on the Quit Ladder6 months

Count of participants who indicated that they were more interested in quitting smoking than at baseline

Types of Assistance Used6 months

count of the types of assistance participants used

Medications Used6 months

count of participant split by tobacco treatment medications used during quit attempts

7-day Abstinence6 months

Count of participants who have not smoked in the past 7 days

Cut Down in Heaviness of Smoking6 months

Cut down by 10 cigarettes per day or in frequency of smoking from daily to some days

Care Coordination60 days

Proportion of participants who completed a care coordination call

Number of Quit Attempts6 months

Self-reported attempts to quit smoking

30-Day Abstinence6 months

Number of participants who had not smoked any cigarettes in the past 30 days

Quit or Cut Down6 months

Number of participants who have either not smoked in the past 7 days or have cut down in heaviness or frequency

Trial Locations

Locations (1)

Minneapolis VA Health Care System, Minneapolis, MN

🇺🇸

Minneapolis, Minnesota, United States

Minneapolis VA Health Care System, Minneapolis, MN
🇺🇸Minneapolis, Minnesota, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.